Kate Haviland, Chief Operating Officer at Blueprint Medicines Corp (BPMC), sold 1,000 shares at $96.78 ($98K) on 2021-12-13, disclosed to the SEC on 2021-12-15.
Scheduled sale ($98k) by Chief Operating Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $96.78 | 94 | $9K | 9.3% |
| 2 | $97.60 | 411 | $40K | 40.8% |
| 3 | $98.50 | 210 | $21K | 21.0% |
| 4 | $99.65 | 285 | $28K | 28.9% |
| Total | $98.30 avg | 1,000 | $98K | 100% |
| Filing → |
| BPMC | SELL | 2025-01-23 | $319K | — | Filing → |
| BPMC | SELL | 2024-12-03 | $396K | — | Filing → |
| BPMC | SELL | 2024-03-11 | $2.3M | — | Filing → |